BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Covington
US Army
Medtronic
Federal Trade Commission
Deloitte
Citi
Fish and Richardson
Johnson and Johnson

Generated: January 16, 2018

DrugPatentWatch Database Preview

Zidovudine - Generic Drug Details

« Back to Dashboard

What are the generic sources for zidovudine and what is the scope of zidovudine freedom to operate?

Zidovudine
is the generic ingredient in two branded drugs marketed by Viiv Hlthcare, Aurobindo Pharma Ltd, Cipla Ltd, Liaoning Chengda, Luitpold, Aurobindo, Aurobindo Pharma, Cipla, Hec Pharm Usa Inc, Hetero Labs Ltd Iii, Matrix Labs Ltd, Mylan Pharms Inc, Ranbaxy Labs Ltd, and West-ward Pharms Int, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for zidovudine. Fifteen suppliers are listed for this compound. There is one tentative approval for this compound.
Tentative approvals for ZIDOVUDINE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe100MGCAPSULE; ORAL

US Patents and Regulatory Information for zidovudine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Viiv Hlthcare RETROVIR zidovudine SYRUP;ORAL 019910-001 Sep 28, 1989 AA RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hetero Labs Ltd Iii ZIDOVUDINE zidovudine TABLET;ORAL 090092-001 Apr 25, 2008 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla Ltd ZIDOVUDINE zidovudine SYRUP;ORAL 077981-001 Jun 26, 2008 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int ZIDOVUDINE zidovudine TABLET;ORAL 076844-001 Sep 19, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla Ltd ZIDOVUDINE zidovudine CAPSULE;ORAL 078349-001 May 23, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-002 Oct 4, 1996 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Liaoning Chengda ZIDOVUDINE zidovudine INJECTABLE;INJECTION 204538-001 Nov 26, 2013 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Matrix Labs Ltd ZIDOVUDINE zidovudine TABLET;ORAL 200732-001 Feb 23, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd ZIDOVUDINE zidovudine CAPSULE;ORAL 078128-001 Mar 27, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold ZIDOVUDINE zidovudine INJECTABLE;INJECTION 091457-001 May 6, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for zidovudine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viiv Hlthcare RETROVIR zidovudine CAPSULE;ORAL 019655-001 Mar 19, 1987 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine SYRUP;ORAL 019910-001 Sep 28, 1989 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-001 Dec 19, 1995 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine CAPSULE;ORAL 019655-001 Mar 19, 1987 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-002 Oct 4, 1996 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-002 Oct 4, 1996 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine INJECTABLE;INJECTION 019951-001 Feb 2, 1990 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-001 Dec 19, 1995 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine SYRUP;ORAL 019910-001 Sep 28, 1989 ➤ Subscribe ➤ Subscribe
Viiv Hlthcare RETROVIR zidovudine SYRUP;ORAL 019910-001 Sep 28, 1989 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Novartis
Chubb
Chinese Patent Office
Baxter
Deloitte
QuintilesIMS
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot